Dual-pathway inhibition in patients with chronic limb-threatening ischemia requiring reintervention for

Burak Teymen1, Mehmet Emin Öner2, Yiğit Erdağ3

  • 1Department of Cardiology, Emsey Hospital, Kurtköy Pendik, 34912, Istanbul, Turkey. burakteymen@yahoo.com.

Heart and Vessels
|April 22, 2024
PubMed

Insights

New oral anticoagulant (NOAC) therapy significantly improved outcomes for patients undergoing below-the-knee intervention, reducing reocclusion and revascularization rates compared to dual-antiplatelet therapy (DAPT). This NOAC approach offers a promising alternative for managing chronic limb-threatening ischemia.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Pharmacology

Background:

  • Chronic limb-threatening ischemia (CLTI) poses significant challenges, often requiring complex interventions.
  • Endovascular intervention for below-the-knee (BTK) occlusions necessitates strategies to maintain patency and prevent reintervention.
  • Optimizing antithrombotic therapy after BTK intervention is crucial for long-term clinical success.

Purpose of the Study:

  • To evaluate the impact of new oral anticoagulant (NOAC) therapy on clinical outcomes following endovascular intervention for BTK occlusions requiring reintervention.
  • To compare the efficacy and safety of NOAC plus clopidogrel versus dual-antiplatelet therapy (DAPT) in patients with CLTI undergoing BTK reintervention.

Main Methods:

  • Retrospective analysis of 64 patients undergoing endovascular reintervention for BTK occlusions.
  • Patients were divided into two groups: NOAC (rivaroxaban 2.5 mg BID + clopidogrel) and DAPT (clopidogrel + aspirin).
  • Primary endpoints included target vessel reocclusion and target lesion revascularization (TLR) at 1-year follow-up; secondary endpoints were amputation rates and major bleeding events.

Main Results:

  • The NOAC group demonstrated significantly lower rates of TLR (10.7% vs. 32.4%, p=0.043) and target vessel reocclusion (17.8% vs. 41.2%, p=0.048) at 1 year compared to the DAPT group.
  • Amputation rates were numerically lower in the NOAC group (3.6% vs. 11.7%), although not statistically significant (p=0.245).
  • No significant difference in major bleeding events was observed between the NOAC and DAPT groups.

Conclusions:

  • Incorporating NOAC therapy (rivaroxaban + clopidogrel) significantly improves patency and reduces revascularization rates after endovascular BTK reintervention in CLTI patients.
  • NOAC-based therapy appears to be a safe and effective alternative to DAPT, with comparable bleeding risk.
  • Further prospective studies are warranted to confirm these findings and optimize antithrombotic strategies for BTK interventions.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...